Biography and Research Information
OverviewAI-generated summary
Ali S. Taha's research portfolio includes investigations into various aspects of human health, with a focus on gastrointestinal health, infectious diseases, and cardiovascular drug monitoring. He has published work examining the role of the microbiome in gastric mucosal protection, particularly in the context of aspirin use. His research also addresses the challenges posed by synthetic cannabinoid receptor agonists and their potential resurgence as adulterants.
Further contributions to the medical field include work on risk factors and biomarkers associated with COVID-19 infections in Iraqi populations. Taha's scholarly output is substantial, evidenced by 136 total publications and over 3,111 citations, resulting in an h-index of 26. He is recognized as a highly cited researcher and has recently been active, with publications extending into 2025. His collaborative network includes Grover Miller from the University of Arkansas for Medical Sciences, with whom he shares multiple publications.
Metrics
- h-index: 26
- Publications: 134
- Citations: 3,133
Selected Publications
-
The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications (2025)
Collaboration Network
Top Collaborators
Theresa Craigen
5 shared publications
- Users of Aspirin and Non-Steroidal Anti-Inflammatory Drugs Have Fewer and Smaller Dysplastic Polyps - Lessons from Colorectal Cancer Screening Program in Scotland
- Endoscopy Pre- and During COVID-19 Lockdown – Same Outcomes of Upper Gastrointestinal Bleeding Despite Its Severity and Comorbidity
- Tu1388 UPPER GASTROINTESTINAL BLEEDING (UGIB) IN COVID-19 YEARS, 2020-2021: CONTROLLED ANALYSIS OF INCIDENCE, PATIENTS’ CHARACTERISTICS, COMORBIDITY & SEVERITY SCORES, ENDOSCOPIC FINDINGS, AND OUTCOMES.
- P277 Nonvariceal UGI bleeding (NVUGIB) in proton pump inhibitors (PPIs) users. Incidence, endoscopic findings, outcomes, and efficacy vs duration of use
- Sa1349: NONVARICEAL UPPER GI BLEEDING (NVUGIB) IN ESTABLISHED USERS OF PROTON PUMP INHIBITORS (PPIS). PROSPECTIVE EVALUATION OF INCIDENCE, ENDOSCOPIC FINDINGS, OUTCOMES, AND EFFICACY VS DURATION OF PPI USE
Caroline McCloskey
4 shared publications
- Endoscopy Pre- and During COVID-19 Lockdown – Same Outcomes of Upper Gastrointestinal Bleeding Despite Its Severity and Comorbidity
- Tu1388 UPPER GASTROINTESTINAL BLEEDING (UGIB) IN COVID-19 YEARS, 2020-2021: CONTROLLED ANALYSIS OF INCIDENCE, PATIENTS’ CHARACTERISTICS, COMORBIDITY & SEVERITY SCORES, ENDOSCOPIC FINDINGS, AND OUTCOMES.
- P277 Nonvariceal UGI bleeding (NVUGIB) in proton pump inhibitors (PPIs) users. Incidence, endoscopic findings, outcomes, and efficacy vs duration of use
- Sa1349: NONVARICEAL UPPER GI BLEEDING (NVUGIB) IN ESTABLISHED USERS OF PROTON PUMP INHIBITORS (PPIS). PROSPECTIVE EVALUATION OF INCIDENCE, ENDOSCOPIC FINDINGS, OUTCOMES, AND EFFICACY VS DURATION OF PPI USE
Wilson J. Angerson
4 shared publications
- Endoscopy Pre- and During COVID-19 Lockdown – Same Outcomes of Upper Gastrointestinal Bleeding Despite Its Severity and Comorbidity
- Tu1388 UPPER GASTROINTESTINAL BLEEDING (UGIB) IN COVID-19 YEARS, 2020-2021: CONTROLLED ANALYSIS OF INCIDENCE, PATIENTS’ CHARACTERISTICS, COMORBIDITY & SEVERITY SCORES, ENDOSCOPIC FINDINGS, AND OUTCOMES.
- P277 Nonvariceal UGI bleeding (NVUGIB) in proton pump inhibitors (PPIs) users. Incidence, endoscopic findings, outcomes, and efficacy vs duration of use
- Sa1349: NONVARICEAL UPPER GI BLEEDING (NVUGIB) IN ESTABLISHED USERS OF PROTON PUMP INHIBITORS (PPIS). PROSPECTIVE EVALUATION OF INCIDENCE, ENDOSCOPIC FINDINGS, OUTCOMES, AND EFFICACY VS DURATION OF PPI USE
Huned Materwala
Khalifa University of Science and Technology (AE)
2 shared publications
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
Shashidhar Naik
Khalifa University of Science and Technology (AE)
2 shared publications
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
Tala Abdulrahman Abed
Khalifa University of Science and Technology (AE)
2 shared publications
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
Davor Svetinović
Khalifa University of Science and Technology (AE)
2 shared publications
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
- Maximal Extractable Value in Decentralized Finance: Taxonomy, Detection, and Mitigation
C McCloskey
1 shared publication
- Users of Aspirin and Non-Steroidal Anti-Inflammatory Drugs Have Fewer and Smaller Dysplastic Polyps - Lessons from Colorectal Cancer Screening Program in Scotland
Angerson Wj
1 shared publication
- Users of Aspirin and Non-Steroidal Anti-Inflammatory Drugs Have Fewer and Smaller Dysplastic Polyps - Lessons from Colorectal Cancer Screening Program in Scotland
Rafah Salih
University of Technology - Iraq (IQ)
1 shared publication
- Determination of Risk Factors and Some Biomarkers Parameters during Infected Iraqis with Covid-19
Nadira Mohamed
Ministry of Health (IQ)
1 shared publication
- Determination of Risk Factors and Some Biomarkers Parameters during Infected Iraqis with Covid-19
Yasmin Iman
Orthopaedic Innovation Centre (CA)
1 shared publication
- Patient Navigators for CKD and Kidney Failure: A Systematic Review
Jay Hingwala
University of Manitoba (CA)
1 shared publication
- Patient Navigators for CKD and Kidney Failure: A Systematic Review
Nicole Askin
University of Manitoba (CA)
1 shared publication
- Patient Navigators for CKD and Kidney Failure: A Systematic Review
Priyanka Mysore
Orthopaedic Innovation Centre (CA)
1 shared publication
- Patient Navigators for CKD and Kidney Failure: A Systematic Review
Similar Researchers
Based on overlapping research topics
Shi J. Liu
University of Arkansas for Medical Sciences
Microbial infections and disease research
SARS-CoV-2 and COVID-19 Research
Meta-analysis and systematic reviews
Maria Schuller De Almeida
University of Arkansas for Medical Sciences
Gut microbiota and health
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Katharine Darland
University of Arkansas for Medical Sciences
Microbial infections and disease research
Meta-analysis and systematic reviews
Pharmacological Effects and Toxicity Studies
JL Mehta
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Cardiovascular Function and Risk Factors
Meta-analysis and systematic reviews
Bader Semakieh
University of Arkansas – Fort Smith
Gut microbiota and health
Microbial infections and disease research
Cardiovascular Function and Risk Factors
Sangam Kandel
University of Arkansas for Medical Sciences
Gut microbiota and health
Microbial infections and disease research
SARS-CoV-2 and COVID-19 Research